We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

Hiden Isochema is a world leader and specialist in the design and manufacture of vapor and gas sorption instruments for research, development and production applications.

We offer a range of sorption analyzers and laboratory services for the characterization of interactions with pharmaceuticals including water sorption isotherms, surface area and porosity, amorphous phase content, hydration analysis and the determination of diffusion coefficients and vapor permeation.

Our IGAsorp gravimetric dynamic vapor sorption analyzer is firmly established as a market leader and is used in many high profile academic, R&D and manufacturing environments within the UK and worldwide.

You’ve known us for decades as the makers of Avicel® and METHOCEL™ and many other strong brands, and we’re building on that history while embracing a future of new possibilities. With decades of vital experience in the pharmaceutical industry, we have a proven track record of working with customers around the globe to differentiate drug formulations and solve the toughest challenges. At IFF Pharma Solutions we provide sustainable cellulosics, seaweed extracts, ultrapure biopolymers and specialized synthetic polymers. This is supported by our polymer expertise and problem-solving mindset across the entire drug development pipeline.

IMCD is a leading global distribution partner and formulator of speciality chemicals and ingredients.

IMCD Pharmaceuticals has a network of six dedicated technical centres and more than 250 sales and marketing experts around the globe. We support our customers and partners at every stage of their product development cycle, from synthesis and extraction of active ingredients, right through to the final product. We serve as an end-to-end partner in the pharmaceutical, nutraceutical, biopharma, synthesis, and agrochemical sectors, to advance ideas for a healthy future.

Our unrivalled technical expertise in excipient performance and functionality, together with our regulatory and quality support, enable us to provide added value every step of the way.

Our 30 years of experience (GLP/GCP/GMP) in the development of complex dosage forms helps to drive our partner’s programs forward daily.

With specialist expertise in orally inhaled & nasal drug product development (OINDPs), we provide analytical testing integrated with formulation and clinical manufacturing capabilities, to support a wide range of projects. Our expertise covers small and large molecules – where we have a dedicated facility for biologics characterisation – and selecting the right delivery platform and device technology to suit your needs.

Our expert analytical services include specific aerosol testing for OINDPs, as well as characterisation and QC testing for various classes of molecules, including DNA therapies, peptides, cell & gene therapies, liposomes, nanoparticles and vaccines. We can also run E&L studies and provide regulatory services through our network of laboratories and consultants.

MeltPrep specializes in laboratory equipment for rapid and lossless prototyping of new dosage forms. Our Vacuum Compression Molding (VCM) technology facilitates formulation screening with mg-to-gram-scale sample molding, ensuring homogeneity directly from powders and eliminating air inclusions.

Providing solutions for a wide range of applications, including Hot Melt Extrusion (HME), Amorphous Solid Dispersions (ASD), and implant formulation screening, the VCM Platform stands out as a versatile tool for pharmaceutical innovation. In addition to a variety of standard sample sizes, it enables the molding of single prototypes to screen dosage forms with complex geometries using Free-D Molding and facilitates the production of filaments for FDM 3D printing through the VCM Filament Molder.

Visit our exhibit at PharmSci 2025 to explore how our VCM technology is accelerating drug formulation and unlocking new possibilities in pharmaceutical development.

Upperton Pharma Solutions is a UK-based contract development and manufacturing organisation (CDMO) specialising in formulation development and clinical trial manufacturing for oral solids, liquids, semi-solids, nasal and inhalation drug products.

Our capabilities and services include Formulation development, Phase 1 to Phase 3 clinical supply, Process scale-up and optimisation, Registration activities and Analytical development and validation. Our defining traits lie in our adaptability and nimbleness, enabling rapid product introduction within 4-6 weeks, and flexibility ensuring that we can problem-solve, meet timescales and deliver solutions that meet patient targets.

Ytron-Quadro have recently celebrated their 40th year of providing processing solutions to the Pharmaceutical and other Manufacturing Sectors.

Established in 1984 by Dudley Bradley the company started by representing Quadro, the originator of the Comil, and YTRON mixing and dispersion equipment.

Since starting, the range of process equipment offered by Ytron-Quadro has grown and now includes Fitzpatrick milling and roller compaction, VMI mixing systems for creams and gels and Labocontrole sampling devices for powders and liquids.

Ytron-Quadro remains a family run company with 3 generations of the Bradley family active in the business.

To find out more click on the link to our website below or visit our stand at PharmSci 2025.